Why Moderna (MRNA) moves
17 explained moves, each written the day it happened. Trade MRNA →
- +9.98%
Raised revenue outlook sends Moderna higher
- +8.69%
Raised revenue outlook sends Moderna higher
- +9.45%
Melanoma vaccine may extend to more cancers
- -20.47%
Vaccine data leak hits Moderna before readout
- -19.53%
Vaccine data leak hits Moderna before readout
- +3.36%
Phase 3 cancer vaccine readout nears, drawing buyers
- +14.01%
Nasdaq-100 inclusion hopes and melanoma data fuel call
- +14.74%
Nasdaq-100 inclusion hopes and melanoma data fuel call
- +6.82%
Tempus therapy deal with Merck and Moderna lifts shares
- +4.12%
Tempus therapy deal with Merck and Moderna lifts shares
- -6.11%
Wall Street downgrade hits Moderna hard
- -5.69%
Patent loss in Bayer vaccine case hits biotech
- +9.07%
Melanoma vaccine data lifts biotech leader
- +11.33%
Melanoma vaccine data lifts biotech leader
- +10.53%
Personalized mRNA skin-cancer shot advances
- +15.33%
Personalized mRNA skin-cancer shot advances
- -26.01%
Moderna pullback as analysts trim rally estimates